体外膜氧合支持期间药物调整专家共识(2025)
该共识由国内临床药学与重症医学多学科专家组制定,围绕ECMO支持期间药物剂量需求变化的原因、药物丢失程度相关因素、需调整的药物类型,以及抗菌药物、抗真菌药物、抗病毒药物、镇静镇痛药物和血管活性药物的调整共8个临床问题展开讨论。基于最新临床证据形成18条共识,旨在为接受ECMO支持的危重症患者药物调整提供推荐,保障用药安全与有效性。
要点
- 共识针对ECMO支持期间药物调整提出8个临床问题,涵盖抗菌药、抗真菌药、抗病毒药、镇静镇痛药和血管活性药。
- ECMO可改变危重症患者的药代动力学参数,从而影响药物在体内的效应。
- 国内此前缺乏ECMO支持期间常用药物调整的推荐,药物选择或剂量调整不明确。
- 共识由国内临床药学与重症医学多学科专家组制定,共形成18条共识。
- 共识基于最新临床证据,旨在为ECMO支持患者的用药安全与有效性提供推荐。
适用人群与场景
- 接受体外膜氧合(ECMO)支持的危重症患者。
研究设计与关键结果
- 共识由国内临床药学与重症医学多学科专家组制定,围绕ECMO支持期间药物调整的8个临床问题形成18条共识。
- 8个临床问题包括:ECMO支持期间患者药物剂量需求变化的原因、药物丢失程度的相关因素、考虑药物特性需调整的药物类型、抗菌药物剂量调整、抗真菌药物调整、抗病毒药物剂量需求是否改变、镇静镇痛药物调整、血管活性药物剂量需求是否受影响。
证据类型、等级与局限
- 证据类型:专家共识。
- 共识基于最新临床证据制定,形成18条共识。
- 局限:原文未报告局限性。
对床旁实践的改变
- 原文未据此给出推荐。
指南或共识出处
- 《体外膜氧合支持期间药物调整专家共识(2025)》,由中华国际医学交流基金会重症医学专家委员会和中国药学会医院药学专业委员会制定。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Extracorporeal membrane oxygenation (ECMO) technology is an important life support method for critically ill patients. A large number of studies have found that ECMO can change the pharmacokinetic (PK) parameters of critically ill patients, thereby affecting the drug effect in vivo. However, there is still a lack of recommendations for the adjustment of commonly used drugs during ECMO support in China, and the selection or dosage adjustment of drugs during ECMO support is not clear. Therefore, a multidisciplinary group of domestic experts in clinical pharmacy and critical care medicine was established by Critical Care Medicine Committee of China International Exchange and Promotive Association for Medical and Health Care, and Hospital Pharmacy Committee of China Pharmaceutical Association, to develop the Expert consensus on drug adjustment during extracorporeal membrane oxygenation support (2025). Eight clinical issues of drug adjustment during ECMO support were discussed in this consensus: (1) Why does the patient's demand for drug dosage change during ECMO support? (2) What factors are related to the degree of drug loss during ECMO support? (3) Considering the features of drugs, which types of drugs may need to be adjusted during ECMO support? (4) How to adjust the dosage when using antibacterial drugs during ECMO support? (5) How to adjust antifungal drugs during ECMO support? (6) Does ECMO support change patients' dosage requirements for antiviral drugs? (7) How to adjust sedative and analgesic drugs during ECMO support? (8) Does ECMO support affect the dosage requirement of vasoactive agents? Eighteen consensus are elaborated based on the latest clinical evidence, aiming to provide recommendations for drug adjustment in critically ill patients receiving ECMO support to ensure the safety and effectiveness of medication.
参考来源
- Critical Care Medicine Committee of China International Exchange and Promotive Association for Medical and Health Care, Hospital Pharmacy Committee of China Pharmaceutical Association. [Expert consensus on drug adjustment during extracorporeal membrane oxygenation support (2025)]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2025. PMID: 41017173. doi:10.3760/cma.j.cn121430-20250304-00213
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。